3-(氯甲基)异喹啉盐酸盐 | 76884-33-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异喹啉及其衍生物
• 中文名称: 3-(氯甲基)异喹啉盐酸盐
• 英文名称: 3-chloromethylisoquinoline hydrochloride
• 英文别名: 3-(chloromethyl)isoquinoline hydrochloride；3-(chloromethyl)isoquinoline;hydrochloride
• CAS: 76884-33-8
• 化学式: C₁₀H₈ClN*ClH
• 分子量: 214.094
• InChiKey: YETGNODBVXTTEB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  12.9
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 海关编码：
  2933499090
• 储存条件：
  2-8℃

反应信息

• 作为反应物：
  描述：

  3-(氯甲基)异喹啉盐酸盐 在 sodium hydroxide 、 sodium azide 、 氯化铵 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 42.0h， 生成 3-{3-[3-(1H-Tetrazol-5-yl)-propoxy]-phenoxymethyl}-isoquinoline
  参考文献：
  名称：

  Development of a novel series of (2-quinolinylmethoxy)phenyl-containing compounds as high-affinity leukotriene receptor antagonists. 1. Initial structure-activity relationships

  摘要：

  This series of reports describes the development of orally active, highly potent, specific antagonists of the peptidoleukotrienes containing a (2-quinolinylmethoxy)phenyl moiety. Described in this first report are the structure-activity relationships that led to a more than a 20-fold improvement of the potency and selectivity of the initial chemical lead (RG 5901). From this series of compounds, RG 7152 (16) was identified and selected for further evaluation in the clinic as an antiasthmatic agent. Compound 16 competitively inhibits [3H]LTD4 binding to membranes from guinea pig lung (Ki = 38 +/- 6 nM) and the spasmogenic activity of LTC4, LTD4, and LTE4 in parenchymal lung strips from guinea pigs. Unlike the original lead (RG 5901), compound 16 does not inhibit 5-lipoxygenase from guinea pig PMNs. Following oral administration to guinea pigs, 16 blocks LTD4-induced dermal permeability (ED50 = 6.9 mg/kg), LTD4-induced bronchoconstriction (ED50 = 1.1 mg/kg), antigen-induced bronchoconstriction (ED50 = 2.5 mg/kg), and anaphylactic-induced mortality (ED50 = 16 mg/kg). These studies on structure-activity relationships indicate that there is a requirement for an acidic function and the presence of the (2-quinolinylmethoxy)phenyl moiety in a specific geometric arrangement.

  DOI：

  10.1021/jm00166a016
• 作为产物：
  描述：

  3-甲醇异喹啉 生成 3-(氯甲基)异喹啉盐酸盐
  参考文献：
  名称：

  Heterocyclic thiazole derivatives and pharmaceutical compositions

  摘要：

  这项发明涉及一种公式I的噻唑化合物，其中Q.sup.1是一个可选择取代的含有一个或两个氮原子的6元单环或10元双环杂环基团；X是氧、硫、亚硫基、磺酰基或亚胺基；Ar是苯基，可以选择携带一个或两个取代基，或者Ar是一个可选择取代的含有最多三个氮原子的6元杂环基团；R.sup.1是氢、(1-6C)烷基、(2-6C)烯基、(2-6C)炔基或取代的(1-4C)烷基；R.sup.2是氢、(1-6C)烷基、(3-6C)烯基、(3-6C)炔基或取代的(1-4C)烷基，或者R.sup.2是可选择取代的苯甲酰基；Q.sup.2是可选择取代的噻唑基；或其药学上可接受的盐。该发明还涉及一种制备公式I的噻唑化合物的方法和含有该噻唑化合物的药物组合物。

  公开号：

  US05089495A1

文献信息

• Iron Catalyzed Highly Enantioselective Epoxidation of Cyclic Aliphatic Enones with Aqueous H₂O₂
  作者：Olaf Cussó、Marco Cianfanelli、Xavi Ribas、Robertus J. M. Klein Gebbink、Miquel Costas

  DOI：10.1021/jacs.5b12681

  日期：2016.3.2

  An iron complex with a C1-symmetric tetradentate N-based ligand catalyzes the asymmetric epoxidation of cyclic enones and cyclohexene ketones with aqueous hydrogen peroxide, providing the corresponding epoxides in good to excellent yields and enantioselectivities (up to 99% yield, and 95% ee), under mild conditions and in short reaction times. Evidence is provided that reactions involve an electrophilic

  具有 C1 对称四齿 N 基配体的铁配合物催化环烯酮和环己烯酮与过氧化氢水溶液的不对称环氧化反应，提供相应的环氧化物，产率和对映选择性都很好（高达 99% 和 95% ee )，条件温和，反应时间短。有证据表明反应涉及亲电氧化剂，并且该元素用于对包含两个烯烃位点的烯酮进行位点选择性环氧化。
• Heterocycles for use as inhibitors of leukotrienes
  申请人：Imperial Chemical Industries PLC

  公开号：US05134148A1

  公开（公告）日：1992-07-28

  The invention concerns a heterocycle of the formula I ##STR1## wherein Q is an optionally substituted 6-membered monocyclic or 10-membered bicyclic heterocyclic moiety containing one or two nitrogen atoms; A is (1-6C)alkylene, (3-6C)alkenylene, (3-6C)alkynylene or cyclo(3-6C)alkylene; X is oxy, thio, sulphinyl, sulphonyl or imino; Ar is phenylene which may optionally bear one or two substituents or Ar is an optionally substituted 6-membered heterocyclene moiety containing up to three nitrogen atoms; R.sup.1 is hydrogen, (1-6C)alkyl, (3-6C)alkenyl, (3-6C)alkynyl, cyano-(1-4C)alkyl or (2-4C)alkanoyl, or optionally substituted benzoyl; and R.sup.2 and R.sup.3 together form a group of the formula --A.sup.2 --X.sup.2 --A.sup.3 -- which, together with the carbon atom to which A.sup.2 and A.sup.3 are attached, defines a ring having 4 to 7 ring atoms, wherein A.sup.2 and A.sup.3, which may be the same or different, each is (1-4C)alkylene and X.sup.2 is oxy, thio, sulphinyl, sulphonyl or imino; or a pharmaceutically-acceptable salt thereof. The compounds of the invention are inhibitors of the enzyme 5-lipoxygenase.

  该发明涉及式I的杂环##STR1##其中Q是一个可选择地取代的含有一个或两个氮原子的6元单环或10元双环杂环基团；A是(1-6C)烷基、(3-6C)烯基、(3-6C)炔基或环(3-6C)烷基；X是氧、硫、亚砜基、磺酰基或亚胺基；Ar是苯基，可以选择性地带有一个或两个取代基，或Ar是一个可选择地取代的含有最多三个氮原子的6元杂环基团；R.sup.1是氢、(1-6C)烷基、(3-6C)烯基、(3-6C)炔基、氰基-(1-4C)烷基或(2-4C)烷酰基，或可选择地取代的苯甲酰基；而R.sup.2和R.sup.3一起形成一个式--A.sup.2--X.sup.2--A.sup.3--的基团，与A.sup.2和A.sup.3连接的碳原子一起定义具有4到7个环原子的环，其中A.sup.2和A.sup.3，可以相同也可以不同，每个是(1-4C)烷基，而X.sup.2是氧、硫、亚砜基、磺酰基或亚胺基；或其药学上可接受的盐。该发明的化合物是5-脂氧合酶的抑制剂。
• Indole derivatives
  申请人：Rhone Poulenc Industries

  公开号：US04261993A1

  公开（公告）日：1981-04-14

  Indole derivatives of the formula: ##STR1## wherein Z represents hydrogen, alkyl of 1 through 10 carbon atoms, or alkoxyalkyl of the formula --(CH.sub.2).sub.n --OR in which R represents alkyl of 1 through 8 carbon atoms and n represents 1 or 2, and their non-toxic pharmaceutically acceptable acid addition salts, are new compunds possessing useful pharmacological properties. They are particularly valuable as analgesic agents; some of them are also useful as anti-inflammatory and antipyretic agents.

  式为：##STR1##的吲哚衍生物，其中Z代表氢、1至10个碳原子的烷基或式为--(CH.sub.2).sub.n --OR（其中R代表1至8个碳原子的烷基，n代表1或2）的烷氧基烷基，以及它们的非毒性药用可接受酸盐，是具有有用药理特性的新化合物。它们特别有价值作为镇痛剂；其中一些还可用作抗炎和退热剂。
• Isoquinoline derivatives
  申请人：Rhone Poulenc Industries

  公开号：US04261992A1

  公开（公告）日：1981-04-14

  Isoquinoline derivatives of the formula: ##STR1## wherein R represents alkyl of 1 through 8 carbon atoms, and n represents 1 or 2, and their non-toxic pharmaceutically acceptable acid addition salts, are new compounds possessing useful pharmacological properties. They are particularly valuable as analgesic agents; some of them are also useful as anti-inflammatory and antipyretic agents.

  公式为##STR1##的异喹啉衍生物，其中R代表1至8个碳原子的烷基，n代表1或2，以及它们的非毒性药学上可接受的酸盐，是具有有用药理学性质的新化合物。它们特别有价值作为镇痛剂；其中一些也可用作抗炎和退烧剂。
• Antiviral isoquinoline derivatives
  申请人：Rhone-Poulenc Industries

  公开号：US04287197A1

  公开（公告）日：1981-09-01

  Isoquinoline derivatives of the formula: ##STR1## wherein R.sub.1 represents alkyl of 1 through 8 carbon atoms, and n represents 1 or 2, are new compounds possessing useful pharmacological properties. They are particularly valuable as analgesic, anti-inflammatory, antipyretic or antiviral agents.

  式为##STR1##其中R.sub.1代表1到8个碳原子的烷基，n代表1或2的异喹啉衍生物是具有有用药理特性的新化合物。它们特别有价值作为镇痛剂、抗炎剂、退烧剂或抗病毒剂。